Despite a reduction in total debt to $83.8 million, the company remains technically insolvent with negative equity of -$51.3 million and a critically low cash position of $2.0 million, which represents less than one week of quarterly R&D spend.
Omeros Corporation (OMER) balance sheet — 19-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 |
|---|
| Total Current Assets | 150.89M | 215.67M | 134.12M | 217.9M | 443.24M | 247.96M | 151.28M | 103.75M | 89.87M | 108.37M | 60.26M | 37.15M | 9.16M | 14.82M | 24.7M | 25.95M | 43.75M | 60.66M | 20.48M | 24.46M |
| Cash & Short-Term Investments | 95.25M | 171.8M | 90.13M | 171.85M | 194.92M | 157.27M | 134.95M | 60.79M | 60.5M | 83.75M | 45.33M | 28.26M | 6.89M | 14.1M | 22.35M | 24.57M | 41.99M | 60.3M | 19.98M | 24.08M |
| Cash Only | 5.07M | 9.66M | 3.4M | 7.11M | 11.01M | 100.81M | 10.5M | 3.08M | 5.86M | 3.39M | 2.22M | 1.36M | 354K | 1.38M | 1.52M | 4M | 3.28M | 820K | 12.73M | 5.92M |
| Short-Term Investments | 90.18M | 162.14M | 86.73M | 164.74M | 183.91M | 56.46M | 124.45M | 57.7M | 54.64M | 80.36M | 43.11M | 26.9M | 6.53M | 12.72M | 20.83M | 20.57M | 38.72M | 59.48M | 7.26M | 18.16M |
| Accounts Receivable | 23.1M | 36.27M | 36.82M | 6.72M | 242.02M | 82.47M | 3.84M | 35.19M | 22.82M | 17.14M | 12.04M | 6.52M | 392K | 379K | 1.93M | 876K | 1.48M | 248K | 207K | 190K |
| Days Sales Outstanding | 145.02 | - | - | - | - | - | - | 114.87 | 278.85 | 96.53 | 105.57 | 176.08 | 265.45 | 86.46 | 117.22 | 70.68 | 256.45 | 62.69 | 64.58 | 36.06 |
| Inventory | 453K | 0 | 0 | 0 | 0 | 0 | 1.35M | 1.15M | 52.51M | 443K | 1.13M | 472K | 568K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 4.08 | - | - | - | - | - | 306.05 | 157.69 | 37.43K | 150 | 291.59 | 165.49 | 7.76 | - | - | - | - | - | - | - |
| Other Current Assets | 25.73M | 7.59M | 7.17M | 30.75M | 6.3M | 67K | 681K | 6.63M | 6.46M | 0 | 0 | 0 | 120K | 86K | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 97.2M | 109.97M | 142.96M | 160.37M | 147.73M | 171.31M | 29.76M | 33.22M | 6.07M | 7.96M | 7.02M | 11.85M | 1.93M | 1.72M | 1.88M | 1.03M | 1.95M | 1.4M | 1.2M | 2.7M |
| Property, Plant & Equipment | 8.25M | 12.48M | 17.64M | 20.58M | 23.25M | 30.01M | 28.08M | 30.91M | 3.85M | 2.12M | 1.18M | 951K | 782K | 939K | 1.04M | 739K | 1.62M | 1.09M | 918K | 839K |
| Fixed Asset Turnover | 7.18x | - | - | - | - | - | - | 3.62x | 7.77x | 30.56x | 35.24x | 14.21x | 0.69x | 1.70x | 5.81x | 6.12x | 1.30x | 1.33x | 1.27x | 2.29x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 60K | 164K |
| Long-Term Investments | 94.77M | 0 | 0 | 0 | 0 | 0 | 0 | 1.15M | 1.15M | 5.83M | 5.83M | 10.68M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 88.95M | 97.49M | 125.32M | 139.79M | 124.48M | 141.31M | 1.68M | 1.16M | 1.07M | 0 | 0 | 219K | 1.15M | 779K | 838K | 295K | 328K | 312K | 225K | 1.7M |
| Total Assets | 248.09M | 325.63M | 277.08M | 378.27M | 590.97M | 419.27M | 181.04M | 136.97M | 95.94M | 116.33M | 67.28M | 48.99M | 11.09M | 16.54M | 26.57M | 26.98M | 45.7M | 62.06M | 21.68M | 27.16M |
| Asset Turnover | 0.26x | - | - | - | - | - | - | 0.82x | 0.31x | 0.56x | 0.62x | 0.28x | 0.05x | 0.10x | 0.23x | 0.17x | 0.05x | 0.02x | 0.05x | 0.07x |
| Asset Growth % | 115.82% | 17.52% | -26.75% | -35.99% | 40.95% | 131.59% | 32.18% | 42.77% | -17.53% | 72.91% | 37.32% | 341.79% | -32.93% | -37.78% | -1.51% | -40.96% | -26.36% | 186.25% | -20.18% | - |
| Total Current Liabilities | 66.57M | 78.06M | 79.53M | 53.32M | 136.38M | 51.79M | 36.74M | 55.46M | 37.36M | 26.31M | 16.07M | 16.25M | 18.43M | 11.87M | 9.32M | 18.98M | 15.87M | 11.09M | 23.56M | 7.93M |
| Accounts Payable | 4.9M | 4.76M | 5.91M | 7.71M | 5.99M | 13.4M | 4.2M | 5.33M | 6.28M | 6.69M | 2.52M | 6.43M | 4.92M | 2.33M | 2.63M | 2M | 2.4M | 2.62M | 1.23M | 2.57M |
| Days Payables Outstanding | 59 | - | - | - | - | 3.53K | 948.41 | 732.47 | 4.48K | 2.27K | 651.16 | 2.25K | 67.12 | 46.39 | 52.05K | - | - | - | - | - |
| Short-Term Debt | 22.34M | 17.06M | 21M | 8.58M | 94.38M | 0 | 0 | 3.5M | 0 | 0 | 0 | 73K | 6.45M | 5.6M | 0 | 5.89M | 395K | 4.93M | 16.56M | 1.01M |
| Deferred Revenue (Current) | 5.29M | 2.47M | 0 | 0 | 0 | 0 | 0 | 0 | -889K | -490K | -198K | 0 | 0 | 0 | 970K | 5.75M | 8.01M | 702K | 232K | 500K |
| Other Current Liabilities | 0 | 30.89M | 29.51M | 0 | 7.82M | 3.71M | 3.95M | 43.08M | 28.36M | 17.44M | 9M | 2.52M | 0 | 0 | 1.42M | 4.98M | 4.09M | 0 | 1.78M | 1.56M |
| Current Ratio | 2.27x | 2.76x | 1.69x | 4.09x | 3.25x | 4.79x | 4.12x | 1.87x | 2.41x | 4.12x | 3.75x | 2.29x | 0.50x | 1.25x | 2.65x | 1.37x | 2.76x | 5.47x | 0.87x | 3.08x |
| Quick Ratio | 2.26x | 2.76x | 1.69x | 4.09x | 3.25x | 4.79x | 4.08x | 1.85x | 1.00x | 4.10x | 3.68x | 2.26x | 0.47x | 1.25x | 2.65x | 1.37x | 2.76x | 5.47x | 0.87x | 3.08x |
| Cash Conversion Cycle | 90.1 | - | - | - | - | - | - | -459.92 | 33.24K | -2.02K | -254 | -1.91K | 206.09 | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 271.5M | 368.8M | 380.16M | 349.94M | 368.9M | 343.7M | 265.06M | 190.53M | -41.58M | 92.83M | 88.65M | 58.98M | 35.31M | 23.05M | 231.83M | 13.55M | 9.36M | 7.83M | 89.29M | 89.17M |
| Long-Term Debt | 162.51M | 208.53M | 166.58M | 329.7M | 220.91M | 313.46M | 236.29M | 158.21M | 148.98M | 83.31M | 79.51M | 49.77M | 26.26M | 14.9M | 20.1M | 13.55M | 9.36M | 7.83M | 118K | 0 |
| Capital Lease Obligations | 18.89M | 7.25M | 13.47M | 18.14M | 22.43M | 29.13M | 28.77M | 32.32M | 1.58M | 810K | 324K | 206K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 106.84M | 153.02M | 200.11M | 2.09M | 125.57M | 1.11M | 0 | 0 | 8.18M | 8.72M | 8.82M | 9M | 9.05M | 8.15M | 3.69M | 0 | 0 | 0 | 89.17M | 89.17M |
| Total Liabilities | 338.07M | 446.86M | 459.69M | 403.25M | 505.29M | 395.49M | 301.79M | 245.99M | -4.22M | 119.14M | 104.72M | 75.23M | 53.74M | 34.92M | 241.15M | 32.54M | 25.23M | 18.92M | 112.85M | 97.1M |
| Total Debt | 193.8M | 239.14M | 207.02M | 361.58M | 342.02M | 347.84M | 268.84M | 194.03M | 151.45M | 84.61M | 80.03M | 49.84M | 32.71M | 20.5M | 20.1M | 19.45M | 9.76M | 12.76M | 16.67M | 1.01M |
| Net Debt | 188.73M | 229.48M | 203.62M | 354.48M | 331.01M | 247.03M | 258.34M | 190.95M | 145.59M | 81.21M | 77.81M | 48.48M | 32.35M | 19.11M | 18.58M | 15.44M | 6.48M | 11.94M | 3.95M | -4.92M |
| Debt / Equity | -2.15x | - | - | - | 3.99x | 14.63x | - | - | 0.23x | - | - | - | - | - | - | - | 0.48x | 0.30x | - | - |
| Debt / EBITDA | -4.72x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | -4.59x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | 3.37x | - | -6.40x | -4.67x | -7.02x | -8.74x | -6.34x | -2.73x | -7.60x | -3.85x | -7.54x | -20.02x | -20.23x | -15.82x | -21.23x | -14.15x | -18.06x | -9.43x | -73.21x | -151.92x |
| Total Equity | -89.97M | -121.23M | -182.61M | -24.98M | 85.68M | 23.78M | -120.75M | -109.02M | 650.13M | -2.81M | -37.45M | -26.23M | -42.65M | -18.38M | -214.58M | -5.55M | 20.47M | 43.15M | -91.17M | -69.94M |
| Equity Growth % | 240.69% | 33.61% | -630.93% | -129.16% | 260.32% | 119.69% | -10.76% | -116.77% | 23203.23% | 92.49% | -42.74% | 38.5% | -132.02% | 91.43% | -3763.47% | -127.13% | -52.56% | 147.33% | -30.35% | - |
| Book Value per Share | -1.23 | -1.91 | -3.14 | -0.40 | 1.37 | 0.38 | -2.11 | -2.20 | 13.38 | -0.06 | -0.93 | -0.70 | -1.28 | -0.64 | -8.88 | -0.25 | 0.96 | 5.98 | -8.48 | -4.90 |
| Total Shareholders' Equity | -89.97M | -121.23M | -182.61M | -24.98M | 85.68M | 23.78M | -120.75M | -109.02M | 650.13M | -2.81M | -37.45M | -26.23M | -42.65M | -18.38M | -214.58M | -5.55M | 20.47M | 43.15M | -91.17M | -69.94M |
| Common Stock | 742K | 716K | 580K | 611K | 628K | 626K | 616K | 542K | 490K | 482K | 438K | 380K | 342K | 304K | 259K | 224K | 219K | 213K | 57K | 56K |
| Retained Earnings | -901.76M | -913.7M | -910.35M | -753.53M | -635.72M | -683.13M | -872.67M | -734.61M | 650.13M | -523.37M | -469.89M | -403.14M | -328.05M | -254.37M | -214.58M | -176.13M | -147.59M | -118.34M | -97.25M | -73.42M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.25M | -3.28M | -2.73M | -2.43M | -2.23M | -2.09M | -1.79M | -2.48M | -2.08M | 41K | -99K | -4K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying OMER stock.
As of 2025, Omeros Corporation (OMER) had total assets of $325.6M including $215.7M in current assets.
Omeros Corporation (OMER) carries total debt of $239.1M, offset by $171.8M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Omeros Corporation (OMER) has total shareholders' equity (book value) of $-121.2M ($-1.91 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Omeros Corporation (OMER) reported a current ratio of 2.76x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Critical liquidity and regulatory risk
Metrics are mathematically derived from official filings.
Leverage Easing Amidst Persistent Insolvency
Omeros's balance sheet has shown a marked improvement in leverage, with total debt declining from $472.1M in Q1 2024 to $83.8M in Q2 2026, yet the company remains technically insolvent with negative equity of -$51.3M.
The significant reduction in total debt suggests a strategic deleveraging, likely through conversions or repayments, which has improved the debt profile. However, the persistent negative equity, driven by accumulated retained earnings deficits exceeding $844 million, indicates that the company's historical losses continue to outweigh its asset base, signaling a fragile financial foundation despite the recent debt reduction.
Cash Position Signals Imminent Dilution
With only $2.0 million in cash as of Q2 2026, Omeros's liquidity is critically constrained, representing less than one week of the $13.8 million quarterly R&D spend reported in the same period.
The current ratio of 1.95 appears adequate on the surface, but the composition of current assets is dominated by non-cash items, as evidenced by the minimal cash balance. This severe cash shortfall, especially in the context of a high fixed-cost R&D structure, strongly suggests that a near-term capital raise is necessary to fund ongoing operations and clinical trials, which would likely be highly dilutive to existing shareholders.
Accumulated Deficits Undermine Equity Base
Omeros's total equity stands at a negative $51.3 million, a direct result of cumulative retained earnings deficits that have ballooned to $844.4 million, reflecting years of unprofitable operations.
The negative equity position is a stark indicator of the company's history of funding its pipeline through equity issuances and debt rather than internal cash generation. The recent improvement from a deficit of over $1 billion in Q3 2025 suggests some liability restructuring, but the core issue of persistent operating losses eroding the equity base remains unresolved, making the balance sheet highly vulnerable to any operational setbacks.
Debt Maturity Wall Masked by Current Ratio
The reported current ratio of 1.95 in Q2 2026 may be misleading, as it does not fully capture the potential near-term liquidity pressure from the $83.8 million in total debt, which could include significant current maturities.
While the current ratio suggests short-term solvency, the dramatic swing in total debt from $310.6M in Q1 2026 to $83.8M in Q2 2026 implies a major debt event, such as a conversion or repayment. Investors should scrutinize the debt's maturity schedule, as any large upcoming principal payment could rapidly deplete the minimal cash reserves and force an emergency financing event, invalidating the apparent stability suggested by the headline current ratio.